Successful Percutaneous Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation in a High-risk Patient with Cardiorenal Syndrome

Mutlu D., Inanc I. H., Mutlu O. P. Z., Marmagkiolis K., Iliescu C. A., Cilingiroglu M.

US Cardiology Review, vol.18, 2024 (Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: 18
  • Publication Date: 2024
  • Doi Number: 10.15420/usc.2024.19
  • Journal Name: US Cardiology Review
  • Journal Indexes: Scopus, Directory of Open Access Journals
  • Keywords: Aortic regurgitation, cardiorenal syndrome, transcatheter aortic valve replacement
  • Istanbul University-Cerrahpasa Affiliated: Yes

Abstract

The absence of a Food and Drug Administration-approved percutaneous valve technology for the treatment of severe aortic regurgitation (AR) presents a challenge for high-risk patients. In this report, we describe the successful treatment of an 84-year-old male patient suffering from severe symptomatic AR and concomitant cardiorenal syndrome with renal failure using a 34 mm Evolut R (Medtronic) self-expanding transcatheter aortic valve replacement. This intervention resulted in the resolution of AR, cardiorenal syndrome, and congestive heart failure symptoms.